Form 4: Zenas BioPharma CEO Leon O. Moulder Jr. Increases Stake in Company
SEC Form 4 Filing
Zenas BioPharma's CEO, Leon O. Moulder Jr., has been actively purchasing company stock, increasing his indirect holdings.
Summary
- Leon O. Moulder Jr., CEO of Zenas BioPharma, has reported several transactions involving the purchase of ZBIO common stock.
- These purchases occurred between September 18 and September 20, 2024.
- The purchases were made at varying prices, ranging from $17.50 to $19.24 per share.
- Mr. Moulder's indirect beneficial ownership of ZBIO shares has increased to 1,672,039 shares.
- These shares are held through Tellus BioVentures LLC, where Mr. Moulder serves as the Managing Member.
- Mr. Moulder disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's stock purchases could indicate confidence, but it's a routine transaction and the CEO disclaims full beneficial ownership of some shares.
Positives
- The CEO's stock purchases could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Management Comments
- Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Industry Context
Insider buying is often monitored by investors as an indicator of management's sentiment regarding the company's valuation and future performance. It's a common practice, and the SEC requires transparency through filings like Form 4.
Stakeholder Impact
- Shareholders may view the CEO's stock purchases as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 09/18/2024 | Purchase of 10,000 shares of common stock at a weighted average price of $17.91. |
| 09/19/2024 | Purchase of 5,000 shares of common stock at a weighted average price of $17.89. |
| 09/20/2024 | Purchase of 2,367 shares of common stock at a weighted average price of $17.88 and 2,633 shares at $18.97. |
| 09/20/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.